WuXi XDC Cayman Inc
2268
株式のランク
#1885
WuXi XDC Cayman Inc. operates as an investment holding company and a global... WuXi XDC Cayman Inc. operates as an investment holding company and a global contract research, development, and manufacturing organization (CRDMO), with operations spanning China, North America, Europe, and other international regions. The company's expertise covers the entire lifecycle, from discovery and research to development and manufacturing, of biopharmaceutical products. Specifically, it focuses on antibody-drug conjugates (ADCs), various bioconjugates, monoclonal antibody intermediates, and the crucial payload-linkers integral to bioconjugate synthesis. Founded in 2013 and headquartered in Wuxi, China, WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc.
株価
$8.78
時価総額
$11.12B
変化（1日）
-9.52%
変化（1年）
0.57%
国
CN
取引 WuXi XDC Cayman Inc (2268)
カテゴリー
Healthcare
WuXi XDC Cayman Inc（2268）のP/B比率
October 2026 時点のP/B比率 TTM: 6.53
WuXi XDC Cayman Inc の最新の財務報告および株価によると、現在のP/B比率（TTM）は 6.53 です。2024 年末時点でのP/B比率は 5.20 でした。
WuXi XDC Cayman Inc の P/B 比率の履歴（2020 ～ 2026）
各年末時点のP/B比率
| 年 | P/B比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 6.53 | -2.87% |
| 2025 | 6.72 | 29.37% |
| 2024 | 5.20 | -10.37% |
| 2023 | 5.80 | -70.54% |
| 2022 | 19.68 | -98.47% |
| 2021 | 1.29K | 1,641.63% |
| 2020 | 73.89 | 0.00% |
同業他社のP/B比率
| 企業 | P/B比率 | P/B比率の差 | 国 |
|---|---|---|---|
| 4.7411 | -27.36% |
US
|
|
| 3.0725 | -52.93% |
US
|
|
| 31.4903 | 382.47% |
US
|
|
| 4.9326 | -24.43% |
CN
|
|
| 6.8081 | 4.31% |
US
|
